FRANCE-HEALTH-WOMEN-CONTRACEPTION : Photo d'actualité

FRANCE-HEALTH-WOMEN-CONTRACEPTION

Crédits : 
MARTIN BUREAU / Employé
Dominique Maraninchi (2ndR), head of France's regulator the National Agency for the Safety of Drugs and Health Products (ANSM) speaks next to Ansm staff members, Francois Hebert (L), Carole Le Saulnier (R) and Pascale Maisonneuve, during a press conference on acne pill Diane 35, on January 30, 2013 in Paris. In the latest health scare to erupt in France, a drug watchdog on Wednesday announced it was suspending sales of an acne pill also used as a contraceptive after four women died and more than 100 others fell ill with blood clots. The National Agency for the Safety of Drugs and Health Products (ANSM) said it was suspending sales of a hormonal treatment called Diane-35, which is prescribed to 315,000 women in France. the product, made by the German firm Bayer, is authorised for treating acne in young women, but doctors have been prescribing it as a contraceptive because it stops ovulation, he said. AFP PHOTO MARTIN BUREAU (Photo credit should read MARTIN BUREAU/AFP/Getty Images)
Légende :
Dominique Maraninchi (2ndR), head of France's regulator the National Agency for the Safety of Drugs and Health Products (ANSM) speaks next to Ansm staff members, Francois Hebert (L), Carole Le Saulnier (R) and Pascale Maisonneuve, during a press conference on acne pill Diane 35, on January 30, 2013 in Paris. In the latest health scare to erupt in France, a drug watchdog on Wednesday announced it was suspending sales of an acne pill also used as a contraceptive after four women died and more than 100 others fell ill with blood clots. The National Agency for the Safety of Drugs and Health Products (ANSM) said it was suspending sales of a hormonal treatment called Diane-35, which is prescribed to 315,000 women in France. the product, made by the German firm Bayer, is authorised for treating acne in young women, but doctors have been prescribing it as a contraceptive because it stops ovulation, he said. AFP PHOTO MARTIN BUREAU (Photo credit should read MARTIN BUREAU/AFP/Getty Images)
Calculer le prixVoir le panier
Date de création :
30 janvier 2013
Editorial - n° :
160367873
Restrictions :
Contactez votre agence locale pour toute utilisation commerciale ou promotionnelle. Droits éditoriaux complets - Royaume-Uni, USA, Irlande, Italie, Espagne, Canada (exclut le Québec). A l'exception de ces pays, les droits éditoriaux sont limités. Veuillez nous contacter.
Type de licence :
Droits gérésLes droits des images de droits gérés sont cédés individuellement pour chaque utilisation. Le prix est calculé à partir de plusieurs facteurs tels que le tirage, la taille et l'emplacement de l'image, la durée d'utilisation, et le territoire de diffusion. Vous devrez renseigner des informations concernant l'utilisation que vous comptez faire du produit, afin de déterminer les droits d'utilisation de ce dernier.
Collection :
AFP
Taille max. de fichier :
4 928 x 3 280 px (173,85 x 115,71 cm) - 72 dpi - 4,8 Mo
Infos autorisations :
Autorisation non disponible.Plus d'infos
Source :
AFP
Code barre :
AFP
Référence :
Par7459315

Mots-clés

Cette image est protégée par la loi sur le droit d'auteur. Getty Images se réserve le droit d'engager des poursuites en cas d’utilisation non autorisée de cette image ou de ce plan-séquence et de demander réparation pour violation de droits d'auteur. La disponibilité de cette image ne peut pas être garantie avant l'achat.
Dominique Maraninchi head of France's regulator the National Agency... Photo d'actualité 160367873Comprimés,Conférence de presse,Diane,France,Horizontal,Métier,Paris - France,Parler,Personne humaine,Santé et médecine,TêtePhotographer Collection: AFP 2013 AFPDominique Maraninchi (2ndR), head of France's regulator the National Agency for the Safety of Drugs and Health Products (ANSM) speaks next to Ansm staff members, Francois Hebert (L), Carole Le Saulnier (R) and Pascale Maisonneuve, during a press conference on acne pill Diane 35, on January 30, 2013 in Paris. In the latest health scare to erupt in France, a drug watchdog on Wednesday announced it was suspending sales of an acne pill also used as a contraceptive after four women died and more than 100 others fell ill with blood clots. The National Agency for the Safety of Drugs and Health Products (ANSM) said it was suspending sales of a hormonal treatment called Diane-35, which is prescribed to 315,000 women in France. the product, made by the German firm Bayer, is authorised for treating acne in young women, but doctors have been prescribing it as a contraceptive because it stops ovulation, he said. AFP PHOTO MARTIN BUREAU (Photo credit should read MARTIN BUREAU/AFP/Getty Images)